The efficacy and safety of Huaiqihuang Granule in the treatment of childhood chronic primary immune thrombocytopenia: a multi-centre, randomized, double-blind, placebo-controlled clinical study ( )
Open Access
- 18 December 2025
- journal article
- research article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 359, 121050
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 15 references indexed in Scilit:
- Investigation of the Active Compounds and Important Pathways of Huaiqihuang Granule for the Treatment of Immune Thrombocytopenia Using Network Pharmacology and Molecular DockingBioMed Research International, 2023
- Huaier granule prolongs overall survival after curative resection of hepatocarcinoma carcinoma: A propensity score analysisJournal of Ethnopharmacology, 2022
- Immune Thrombocytopenia in Children: Consensus and ControversiesIndian Journal of Pediatrics, 2020
- Switching thrombopoietin receptor agonist treatments in patients with primary immune thrombocytopeniaTherapeutic Advances in Hematology, 2019
- Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid contentPlatelets, 2018
- Incidence of childhood primary immune thrombocytopenic purpuraPediatrics International, 2015
- Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopeniaNature Communications, 2015
- B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cellsJournal of Clinical Investigation, 2012
- Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopeniaAnnals of Hematology, 2012
- Childhood Immune Thrombocytopenic Purpura: Diagnosis and ManagementHematology/Oncology Clinics of North America, 2010